In a study comparing patients with NAFLD with healthy control individuals, significant associations were found between GCKR rs780094 and susceptibility to NAFLD (OR 1.49), NASH (OR, 1.55), and NASH with significant fibrosis (OR, 1.50) [115]. The gene discussed is GCKR; the disease is metabolic dysfunction-associated steatotic liver disease.